Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PDE4 as a target in preterm labour.

Céline Méhats1, Thomas Schmitz, Stéphanie Oger

  • 1Institut National de la Santé et de la Recherche Médicale, INSERM U767, Paris cedex 06, France. mehats@cochin.inserm.fr

BMC Pregnancy and Childbirth
|June 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Respiratory evolution after antenatal betamethasone dose reduction in very preterm neonates: a post hoc analysis of the BETADOSE trial.

European journal of pediatrics·2026
Same author

Counseling practices, opinions and personal preferences regarding mode of delivery for term breech presentation: A survey of healthcare professionals.

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

Dexmedetomidine Preserves Hippocampal Neurogenesis During Recovery from Neonatal Hyperoxia in Rats.

Cells·2026
Same author

Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial.

Circulation·2026
Same author

[From exclusion to responsible inclusion: Rethinking pregnant women in clinical research].

Gynecologie, obstetrique, fertilite & senologie·2026
Same author

Early outcomes of redo-TAVI with the SAPIEN 3 platform: the prospective, multicentre ReTAVI registry.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Cyclic nucleotide phosphodiesterases (PDEs) regulate uterine contractions. PDE4B2 expression increases in late pregnancy, potentially hindering tocolytic drugs and contributing to preterm birth. PDE4 inhibitors show promise in preventing inflammation-induced preterm delivery.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Reproductive Biology

Background:

  • Cyclic nucleotide phosphodiesterases (PDEs) inactivate cAMP and cGMP.
  • PDE4 inhibitors are used for inflammatory disorders and cardiovascular conditions.
  • PDE4 isoforms are implicated in smooth muscle function and inflammation.

Purpose of the Study:

  • Investigate PDE4B2 expression in human myometrium.
  • Determine the role of PDE4B2 in myometrial contractility and inflammation.
  • Evaluate PDE4 inhibitors as a therapeutic strategy for preterm birth.

Main Methods:

  • Quantitative analysis of PDE4B2 expression in myometrial tissue.
  • In vitro studies using cultured human myometrial cells.
  • Assessment of PDE4 inhibitor efficacy in mouse models of preterm birth.

Related Experiment Videos

Main Results:

  • PDE4B2 expression is upregulated in near-term human myometrium.
  • PGE2 and IL-1beta induce PDE4B2 expression in myometrial cells.
  • Increased PDE4 activity impairs beta-adrenergic agonist-mediated inhibition of myometrial contraction.
  • PDE4 inhibitors block inflammation in fetal membranes and prevent preterm birth in mice.

Conclusions:

  • PDE4B2 plays a role in regulating myometrial contractility during pregnancy.
  • PDE4 inhibitors represent a potential therapeutic approach for preventing preterm birth.
  • Targeting PDE4 may offer a novel strategy against inflammation-related pregnancy complications.